• Analysis of First-Line EGFR Medications for Non-Small Cell Lung Cancer: Based on the NCCN Clinical Practice Guidelines in Oncology (NSCLC, Version 1.2026)

  Application Note: This content is compiled based on the NCCN Clinical Practice Guidelines in Oncology for Non-Small Cell Lung Cancer (Version 1.2026),···【Read More】

  Update: 17 Sep,2026Source: BigbearViews: 278

• BigBear Pharma: Statement on the Investigation into Quality Defects of Sealing Stickers on Certain Drug Products

  Dear Customers, Partners, and Relevant Parties,During a recent product quality inspection bigbear pharma discovered that the sealing stickers used on ···【Read More】

  Update: 10 Sep,2026Source: BigbearViews: 196

• Selpercatinib (SEPADX) manufactured by BigBear Pharma has received approval in Laos

  Vientiane, Laos - November 20, 2023 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer ···【Read More】

  Update: 18 Aug,2026Source: BigbearViews: 210

• Ivosidenib (AIVODX) manufactured by Big Bear Pharma has been approved in Laos

  Vientiane, Laos - January 3, 2024 - BigBearPharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer the···【Read More】

  Update: 08 Jun,2026Source: BigbearViews: 325

• Trelagliptin (TEGLIDX) produced by BigBear Pharma has been approved in Laos

  Vientiane, Laos - January 3, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovative···【Read More】

  Update: 08 Jun,2026Source: BigbearViews: 317

• Selumetinib (SEMEDX) produced by BigBearPharma has been approved in Laos

  Vientiane, Laos - April 8, 2024 - BigBearPharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer thera···【Read More】

  Update: 04 Jun,2026Source: BigbearViews: 337

• BigBear Pharma Announces Approval of Baricitinib (BARUDX) in Laos

  Vientiane, Laos - April 8, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovative c···【Read More】

  Update: 03 Jun,2026Source: BigbearViews: 362

• Laos Big Bear Pharma: A New Force in Generic Drugs Rising from the Heart of Southeast Asia

  On the banks of the Mekong River in Laos, a transformation in healthcare accessibility is quietly taking place. As the Lao government continues to inc···【Read More】

  Update: 02 Jun,2026Source: BigbearViews: 483

• BigBear Pharma Announces Approval of Larotrectinib (LARODX) in Laos

  Vientiane, Laos - May 30, 2024 - BIGBEARPharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer therap···【Read More】

  Update: 02 Jun,2026Source: BigbearViews: 301

• BigBear Pharma Announces Approval of Adagrasib (ADADX) in Laos

  Vientiane, Laos – July 14, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovative c···【Read More】

  Update: 01 Jun,2026Source: BigbearViews: 309

• Tazemetostat (TAZEDX) manufactured by Big Bear Pharmaceutical has been approved in Laos

  Vientiane, Laos, August 01, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer tre···【Read More】

  Update: 27 May,2026Source: BigbearViews: 284

• BigBear Pharma announces that Olaparib (OLADX) has been approved in Laos

  September 20, 2024 - Vientiane, Laos - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer···【Read More】

  Update: 26 May,2026Source: BigbearViews: 276

• BigBearPharma announces that Letermovir (LETEDX) has been approved in Laos

  September 20, 2024 - Vientiane, Laos - BigBearPharma, a leading biopharmaceutical company focused on developing and commercializing innovative therapi···【Read More】

  Update: 26 May,2026Source: BigbearViews: 657

• BigBear Pharma Announces Approval of Pralsetinib (PRASEDX) in Laos

  Vientiane, Laos, August 12, 2024 - BigBear Pharma, a leading biopharmaceutical company focused on developing and commercializing innovative cancer tre···【Read More】

  Update: 22 May,2026Source: BigbearViews: 244

• Lusutrombopag manufactured by BigBear Pharmaceuticals approved in Laos

  Vientiane, Laos – October 08, 2024 – BigBear Pharma, a leading biopharmaceutical company focused on the development and commercialization of innovativ···【Read More】

  Update: 21 May,2026Source: BigbearViews: 278